ID   MHCC97-L
AC   CVCL_4973
SY   MHCC 97-L; MHCC97L
DR   BTO; BTO:0004170
DR   Cosmic; 2773183
DR   GEO; GSM501783
DR   GEO; GSM936772
DR   GEO; GSM1374676
DR   Wikidata; Q54905534
RX   PubMed=11819844;
RX   PubMed=15048980;
RX   PubMed=15146329;
RX   PubMed=23505090;
RX   PubMed=32884988;
CC   Population: Chinese.
CC   Characteristics: Low metastatic potential.
CC   Karyotypic information: Has lost chromosome Y.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4971 ! MHCC97
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 16
//
RX   PubMed=11819844; DOI=10.3748/wjg.v7.i5.630;
RA   Li Y., Tang Z.-Y., Ye S.-L., Liu Y.-K., Chen J., Xue Q., Chen J.,
RA   Gao D.-M., Bao W.-H.;
RT   "Establishment of cell clones with different metastatic potential from
RT   the metastatic hepatocellular carcinoma cell line MHCC97.";
RL   World J. Gastroenterol. 7:630-636(2001).
//
RX   PubMed=15048980; DOI=10.1002/pmic.200300653;
RA   Ding S.-J., Li Y., Shao X.-X., Zhou H., Zeng R., Tang Z.-Y.,
RA   Xia Q.-C.;
RT   "Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H
RT   and MHCC97-L, with different metastasis potentials.";
RL   Proteomics 4:982-994(2004).
//
RX   PubMed=15146329; DOI=10.1007/s00432-004-0564-9;
RA   Li Y., Tian B., Yang J., Zhao L., Wu X., Ye S.-L., Liu Y.-K.,
RA   Tang Z.-Y.;
RT   "Stepwise metastatic human hepatocellular carcinoma cell model system
RT   with multiple metastatic potentials established through consecutive in
RT   vivo selection and studies on metastatic characteristics.";
RL   J. Cancer Res. Clin. Oncol. 130:460-468(2004).
//
RX   PubMed=23505090; DOI=10.1002/hep.26402;
RA   Wang K., Lim H.Y., Shi S., Lee J., Deng S.-B., Xie T., Zhu Z.,
RA   Wang Y.-L., Pocalyko D., Yang W.J., Rejto P.A., Mao M., Park C.-K.,
RA   Xu J.-C.;
RT   "Genomic landscape of copy number aberrations enables the
RT   identification of oncogenic drivers in hepatocellular carcinoma.";
RL   Hepatology 58:706-717(2013).
//
RX   PubMed=32884988; DOI=10.1016/j.gendis.2019.12.008;
RA   Lin Y.-L., Li Y.;
RT   "Study on the hepatocellular carcinoma model with metastasis.";
RL   Genes Dis. 7:336-350(2020).
//